购物车
- 全部删除
- 您的购物车当前为空
PPARδ agonisT 11(Compound 11)作为一种具有选择性的PPARδ激动剂,其EC50值为20 nM。此化合物能有效降低LPS刺激下RAW264.7细胞产生的一氧化氮(NO)、TNFα和IL-6等促炎细胞因子,展现其通过NF-κB通路的抗炎活性。在人肝微粒体和血浆中,PPARδ agonisT 11展现出优异的稳定性。此外,该化合物能显著改善Carrageenan引起的足部水肿,其药代动力学表现良好,生物利用度高达100%。
PPARδ agonisT 11(Compound 11)作为一种具有选择性的PPARδ激动剂,其EC50值为20 nM。此化合物能有效降低LPS刺激下RAW264.7细胞产生的一氧化氮(NO)、TNFα和IL-6等促炎细胞因子,展现其通过NF-κB通路的抗炎活性。在人肝微粒体和血浆中,PPARδ agonisT 11展现出优异的稳定性。此外,该化合物能显著改善Carrageenan引起的足部水肿,其药代动力学表现良好,生物利用度高达100%。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 期货 | |
50 mg | 询价 | 期货 |
产品描述 | Compound 11, a selecTive PPARδ agonisT, demonsTraTes an EC50 of 20 nM, indicaTing iTs high affiniTy for PPARδ recepTors. This compound efficienTly reduces levels of niTric oxide (NO), as well as The pro-inflammaTory cyTokines TNFα and IL-6 in LPS-sTimulaTed RAW264.7 cells via The NF-κB paThway, showcasing iTs anTi-inflammaTory properTies. AddiTionally, Compound 11 exhibiTs remarkable sTabiliTy in human liver microsomes and plasma. IT significanTly amelioraTes fooT edema induced by Carrageenan, displaying favorable pharmacokineTic properTies wiTh a bioavailabiliTy of approximaTely 100%. |
靶点活性 | PPARδ (human):0.02 μM (EC50), PPARα (human):8 μM (EC50) |
分子量 | 440.46 |
分子式 | C19H15F3N2O3S2 |
CAS No. | 2982696-04-6 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容